Is This Clinical Trial Fully Registered?

August 2005
Croatian Medical Journal;2005, Vol. 46 Issue 4, p499
Academic Journal
Discusses the publication of a joint editorial aimed at promoting registration of all clinical trials by the members of the International Committee of Medical Journal Editors in September 2004. Goal of the publication of the joint editorial; List of other international agencies pursuing the goal; Definition of a clinical trial.


Related Articles

  • Academic medicine: time for reinvention. Caan, Woody // BMJ: British Medical Journal (International Edition);1/3/2004, Vol. 328 Issue 7430, p48 

    Presents a letter to the editor regarding the need for national strategies to improve clinical trials and medical research in Great Britain.

  • Clinical Trials in New Europe. DOIG, AL // Bio-IT World;Jan2009, Vol. 8 Issue 1, p13 

    The article presents an outlook for clinical trials in New Europe for 2009. The collapse of the Soviet Union is cited as one of the major factors which contributed to the emergence of new opportunity for clinical trials in Europe. An overview of the report from Insight Pharma Reports entitled...

  • Relevance of the clinical impact factor. Blitzkow, Gilson; Estrela, Carlos // Dental Press Endodontics;Jan-Apr2015, Vol. 5 Issue 1, p5 

    The author discusses the importance of systematic literature reviews to analyze clinical impact factors and select accurate and appropriate articles.

  • Including care home residents in clinical research is fraught.  // BMJ: British Medical Journal (International Edition);11/26/2005, Vol. 331 Issue 7527, p1271 

    The article presents a letter to the editor in response to the article "Including older people in clinical research," " by M. E. T. McMurdo, M. D. Witham, and N. D. Gillespie, in the November 5, 2005 issue.

  • Academic medicine: time for reinvention. Blakemore, Colin; Chalmers, Iain // BMJ: British Medical Journal (International Edition);1/3/2004, Vol. 328 Issue 7430, p49 

    Presents a letter to the editor regarding the plans of the Medical Research Council to give the British National Health Service evidence from randomized clinical trials.

  • clinical trial.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p467 

    An encyclopedia entry for "clinical trial" is presented. It refers to an investigation of drug administration on human subjects to define the clinical efficacy and pharmacological effects. It addresses a variety of issues such as the treatment and diagnosis of disease. Particular focus is given...

  • A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. Thabane, Lehana; Mbuagbaw, Lawrence; Zhang, Shiyuan; Samaan, Zainab; Marcucci, Maura; Chenglin Ye; Thabane, Marroon; Giangregorio, Lora; Dennis, Brittany; Kosa, Daisy; Debono, Victoria Borg; Dillenburg, Rejane; Fruci, Vincent; Bawor, Monica; Juneyoung Lee; Wells, George; Goldsmith, Charles H. // BMC Medical Research Methodology;2013, Vol. 13 Issue 1, p1 

    Background: Sensitivity analyses play a crucial role in assessing the robustness of the findings or conclusions based on primary analyses of data in clinical trials. They are a critical way to assess the impact, effect or influence of key assumptions or variations-such as different methods of...

  • Veteran researchers' advice to new researchers.  // Clinical Trials Administrator;Apr2008, Vol. 6 Issue 4, p42 

    The article reports on the advice given by Doctor Roy Fleischmann, clinical professor of medicine at the University of Texas Southwestern Medical Center in Dallas, Texas, to new researchers in the clinical trial industry. He states that when he started doing studies, they were designed to ask a...

  • The Continuum of Comparability Extends to Biosimilarity: How Much Is Enough and What Clinical Data Are Necessary? McCamish, M; Woollett, G // Clinical Pharmacology & Therapeutics;Apr2013, Vol. 93 Issue 4, p315 

    The article offers information on the comparability and biosimilarity of regulatory and scientific concepts of clinical data in the U.S. It mentions the standards needed to get approval for biologics and biosimilar manufacturing changes. Moreover, it features the needed investments to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics